
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New insights into the treatment of obesity
Matthias Blüher, Mohini Aras, Louis J. Aronne, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2058-2072
Closed Access | Times Cited: 85
Matthias Blüher, Mohini Aras, Louis J. Aronne, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 8, pp. 2058-2072
Closed Access | Times Cited: 85
Showing 1-25 of 85 citing articles:
Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options
Arturo Cesaro, Gianantonio De Michele, Fabio Fimiani, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 48
Arturo Cesaro, Gianantonio De Michele, Fabio Fimiani, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 48
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care
Juan Patricio Nogueira, Kenneth Cusi
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 20-28
Open Access | Times Cited: 41
Juan Patricio Nogueira, Kenneth Cusi
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 20-28
Open Access | Times Cited: 41
Obesity and cardiovascular disease: an ESC clinical consensus statement
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Heart Journal (2024)
Open Access | Times Cited: 41
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Heart Journal (2024)
Open Access | Times Cited: 41
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
Nasreen Alfaris, Stephanie W. Waldrop, Veronica Johnson, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102782-102782
Open Access | Times Cited: 16
Nasreen Alfaris, Stephanie W. Waldrop, Veronica Johnson, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102782-102782
Open Access | Times Cited: 16
Obesity and cardiovascular disease: an ESC clinical consensus statement
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 16
Konstantinos C. Koskinas, Emeline M. Van Craenenbroeck, Charalambos Antoniades, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 16
Self‐Assembled Oligopeptoplex‐Loaded Dissolving Microneedles for Adipocyte‐Targeted Anti‐Obesity Gene Therapy
Hee Kyoung Choi, Juhyeong Hong, Yuha Seo, et al.
Advanced Materials (2024) Vol. 36, Iss. 16
Closed Access | Times Cited: 14
Hee Kyoung Choi, Juhyeong Hong, Yuha Seo, et al.
Advanced Materials (2024) Vol. 36, Iss. 16
Closed Access | Times Cited: 14
Experiences and overall impact reported by people living with obesity: results from a multinational study
Esther Artime, Swarna Khare, Sarah Zimner‐Rapuch, et al.
SAGE Open Medicine (2025) Vol. 13
Open Access | Times Cited: 1
Esther Artime, Swarna Khare, Sarah Zimner‐Rapuch, et al.
SAGE Open Medicine (2025) Vol. 13
Open Access | Times Cited: 1
Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Mariam M. Ali, Sanober Parveen, Vanessa Williams, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100341-100341
Open Access | Times Cited: 7
Mariam M. Ali, Sanober Parveen, Vanessa Williams, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100341-100341
Open Access | Times Cited: 7
Obesity, cardiovascular and cerebrovascular disease: the role of GLP-1 receptor agonists
Amedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
Polskie Archiwum Medycyny Wewnętrznej (2024)
Open Access | Times Cited: 5
Amedeo Tirandi, Fabrizio Montecucco, Federico Carbone, et al.
Polskie Archiwum Medycyny Wewnętrznej (2024)
Open Access | Times Cited: 5
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know
Kenneth Cusi, Jeff Budd, Eric L. Johnson, et al.
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 29-38
Open Access | Times Cited: 4
Kenneth Cusi, Jeff Budd, Eric L. Johnson, et al.
Diabetes Spectrum (2024) Vol. 37, Iss. 1, pp. 29-38
Open Access | Times Cited: 4
Weight Loss Therapies and Hypertension Benefits
Vasiliki Katsi, Eleni Manta, Christos Fragoulis, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2293-2293
Open Access | Times Cited: 4
Vasiliki Katsi, Eleni Manta, Christos Fragoulis, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2293-2293
Open Access | Times Cited: 4
Investigating the impact of microbiome-changing interventions on food decision-making: MIFOOD study protocol
Meghedi Vartanian, Konrad Jakob Endres, Yee Teng Lee, et al.
BMC Nutrition (2025) Vol. 11, Iss. 1
Open Access
Meghedi Vartanian, Konrad Jakob Endres, Yee Teng Lee, et al.
BMC Nutrition (2025) Vol. 11, Iss. 1
Open Access
Efficacy of Bone Graft and Photobiomodulation in Alveolar Preservation: A Case Report in a Post-Bariatric Surgery Patient
Erika da Silva Mello, Glaucia Gonçales Abud Machado, Cícero Dayves da Silva Bezerra, et al.
Journal of Advances in Medicine and Medical Research (2025) Vol. 37, Iss. 1, pp. 119-126
Closed Access
Erika da Silva Mello, Glaucia Gonçales Abud Machado, Cícero Dayves da Silva Bezerra, et al.
Journal of Advances in Medicine and Medical Research (2025) Vol. 37, Iss. 1, pp. 119-126
Closed Access
Preclinical development of a standardized extract of Ilex paraguariensis A.St.-Hil for the treatment of obesity and metabolic syndrome
Sara Emília Lima Tolouei, Rodrigo Marcon, Fabiana C. Vilela, et al.
Pharmacological Research (2025), pp. 107607-107607
Open Access
Sara Emília Lima Tolouei, Rodrigo Marcon, Fabiana C. Vilela, et al.
Pharmacological Research (2025), pp. 107607-107607
Open Access
STING1 targets MYH9 to drive adipogenesis through the AKT/GSK3β/β-catenin pathway
Conghui Guan, Kuan Yang, Chengxu Ma, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151352-151352
Closed Access
Conghui Guan, Kuan Yang, Chengxu Ma, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 749, pp. 151352-151352
Closed Access
Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis
Mahmoud Nassar, Hazem Abosheaishaa, Anoop Misra, et al.
Diabetes & Metabolism (2025), pp. 101613-101613
Closed Access
Mahmoud Nassar, Hazem Abosheaishaa, Anoop Misra, et al.
Diabetes & Metabolism (2025), pp. 101613-101613
Closed Access
Risiko für schwere kardiovaskuläre Ereignisse und Schlaganfall gesenkt
Hans‐Christoph Diener
InFo Neurologie + Psychiatrie (2025) Vol. 27, Iss. 1, pp. 14-14
Closed Access
Hans‐Christoph Diener
InFo Neurologie + Psychiatrie (2025) Vol. 27, Iss. 1, pp. 14-14
Closed Access
Quantitative proteomics and targeted metabolomics reveal the role of Cassia siamea L. extract in the response to high-fat diet-induced obesity in Drosophila
Ananya Dechakhamphu, Nattapong Wongchum, Theeraphan Chumroenphat, et al.
Phytomedicine Plus (2025), pp. 100743-100743
Open Access
Ananya Dechakhamphu, Nattapong Wongchum, Theeraphan Chumroenphat, et al.
Phytomedicine Plus (2025), pp. 100743-100743
Open Access
Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: a systematic review and meta-analysis
Kathryn J. Potter, Jackie Phinney, Tasha Kulai, et al.
Journal of the Canadian Association of Gastroenterology (2025)
Open Access
Kathryn J. Potter, Jackie Phinney, Tasha Kulai, et al.
Journal of the Canadian Association of Gastroenterology (2025)
Open Access
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
Brian Lam, Jessica Bartholomew, Sherona Bau, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Brian Lam, Jessica Bartholomew, Sherona Bau, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Food Chain and Food Policies: Causes and Solutions for the Obesity Pandemic
Nishtha Sareen, Shivani Watson, Nina Hill, et al.
Methodist DeBakey Cardiovascular Journal (2025) Vol. 21, Iss. 2, pp. 14-22
Closed Access
Nishtha Sareen, Shivani Watson, Nina Hill, et al.
Methodist DeBakey Cardiovascular Journal (2025) Vol. 21, Iss. 2, pp. 14-22
Closed Access
Food Bioactives in the Prevention and Clinical Management of Obesity
Alphonse Laya, Eugénia Carvalho, Iva Fernandes, et al.
(2025), pp. 299-327
Closed Access
Alphonse Laya, Eugénia Carvalho, Iva Fernandes, et al.
(2025), pp. 299-327
Closed Access
Dietary therapy to halt the progression of diabetes to diabetic kidney disease
Hongtu Hu, Guohua Ding, Wei Liang
Food & Function (2025)
Open Access
Hongtu Hu, Guohua Ding, Wei Liang
Food & Function (2025)
Open Access
Type of diet has no major influence on inflammatory response in a Saddleback pig model
Lisa Wahl, Stefanie Rau, Christine Dawczynski, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lisa Wahl, Stefanie Rau, Christine Dawczynski, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An overview of obesity‐related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes
Matthias Blüher
Diabetes Obesity and Metabolism (2025)
Open Access
Matthias Blüher
Diabetes Obesity and Metabolism (2025)
Open Access